{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:02:37Z","timestamp":1784599357965,"version":"3.55.0"},"reference-count":70,"publisher":"ARAN Ediciones","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.hipert.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T09:45:49Z","timestamp":1533203149000},"page":"34-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enfoque diagn\u00f3stico de feocromocitomas y paragangliomas"],"prefix":"10.20960","volume":"36","author":[{"given":"R.M.","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hernaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barontini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2018.06.003_bib0355","unstructured":"S.G. Lev\u00edn. Feocromocitoma. En: G\u00f3mez Llamb\u00ed H y Piskorz (eds.). Hipertensi\u00f3n arterial. Cap 95. Interm\u00e9dica; 2013. 451-455."},{"key":"10.1016\/j.hipert.2018.06.003_bib0360","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0032-1306294","article-title":"High incidence of cardiovascular complications in pheochromocytoma","volume":"44","author":"Zelinka","year":"2012","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.hipert.2018.06.003_bib0365","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens."},{"key":"10.1016\/j.hipert.2018.06.003_bib0370","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2018.06.003_bib0375","unstructured":"DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of tumors. Pathology and genetic tumors of endocrine organs. Lyon: IARC Press, 2004. p. 57-66."},{"key":"10.1016\/j.hipert.2018.06.003_bib0380","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","article-title":"Update on modern management of pheochromocytoma and paraganglioma","volume":"32","author":"Lenders","year":"2017","journal-title":"Endocrinol Metab (Seoul)."},{"key":"10.1016\/j.hipert.2018.06.003_bib0385","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0889-8529(18)30104-X","article-title":"Pheochromocytoma","volume":"23","author":"Gifford","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.hipert.2018.06.003_bib0390","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinchem\/38.4.486","article-title":"Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine","volume":"38","author":"Smythe","year":"1992","journal-title":"Clin Chem."},{"key":"10.1016\/j.hipert.2018.06.003_bib0395","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: State-of-the-art and future prospects","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev."},{"key":"10.1016\/j.hipert.2018.06.003_bib0400","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3803\/EnM.2013.28.1.20","article-title":"Clinical characteristics for 348 patients with adrenal incidentaloma","volume":"28","author":"Kim","year":"2013","journal-title":"Endocrinol Metab (Seoul)."},{"key":"10.1016\/j.hipert.2018.06.003_bib0405","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.currproblcancer.2014.01.001","article-title":"Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment","volume":"38","author":"Martucci","year":"2014","journal-title":"Curr Probl Cancer."},{"key":"10.1016\/j.hipert.2018.06.003_bib0415","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1055\/s-0028-1128139","article-title":"The protean manifestations of pheochromocytoma","volume":"41","author":"Manger","year":"2009","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.hipert.2018.06.003_bib0420","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11906-014-0442-z","article-title":"Diagnosis and management of pheochromocytoma: A practical guide to clinicians","volume":"16","author":"Pappachan","year":"2014","journal-title":"Curr Hypertens Rep."},{"key":"10.1016\/j.hipert.2018.06.003_bib0425","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/jc.2003-031234","article-title":"In search of pheochromocytomas","volume":"88","author":"Manger","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0430","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2007.04.012","article-title":"Pheochromocytoma: Advances in genetics, diagnosis, localization, and treatment","volume":"21","author":"Mittendorf","year":"2007","journal-title":"Hematol Oncol Clin North Am."},{"key":"10.1016\/j.hipert.2018.06.003_bib0435","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/EJE-13-0882","article-title":"Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma","volume":"170","author":"Van Berkel","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.hipert.2018.06.003_bib0440","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0445","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","author":"Eisenhofer","year":"2014","journal-title":"Clin Chem."},{"key":"10.1016\/j.hipert.2018.06.003_bib0450","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0455","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma","volume":"134","author":"Pacak","year":"2001","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.hipert.2018.06.003_bib0460","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.2002-021913","article-title":"Biochemical diagnosis of pheochromocytoma--is it time to switch to plasma-free metanephrines?","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0465","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2265.2007.02805.x","article-title":"The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma","volume":"66","author":"Perry","year":"2007","journal-title":"Clin Endocrinol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0470","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1507\/endocrj.EJ13-0277","article-title":"Plasma free metanephrines in the diagnosis of pheochromocytoma: Diagnostic accuracy and strategies for Japanese patients","volume":"61","author":"Tanaka","year":"2014","journal-title":"Endocr J."},{"key":"10.1016\/j.hipert.2018.06.003_bib0475","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1210\/jc.2005-2668","article-title":"Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma","volume":"92","author":"Boyle","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0480","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/clinchem\/39.1.97","article-title":"Determination of metanephrines in plasma by liquid chromatography with electrochemical detection","volume":"39","author":"Lenders","year":"1993","journal-title":"Clin Chem."},{"key":"10.1016\/j.hipert.2018.06.003_bib0485","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00004872-200106000-00006","article-title":"Lessons from an unpleasant surprise: A biochemical strategy for the diagnosis of pheochromocytoma","volume":"19","author":"Gardet","year":"2001","journal-title":"J Hypertens."},{"key":"10.1016\/j.hipert.2018.06.003_bib0490","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: A multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0495","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","author":"Yu","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.hipert.2018.06.003_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6823-5-1","article-title":"Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?","volume":"5","author":"Sawka","year":"2005","journal-title":"BMC Endocr Disord."},{"key":"10.1016\/j.hipert.2018.06.003_bib0505","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.02.00106402","article-title":"Obstructive sleep apnoea and urine catecholamines in hypertensive males: A population-based study","volume":"19","author":"Elmasry","year":"2002","journal-title":"Eur Respir J."},{"key":"10.1016\/j.hipert.2018.06.003_bib0510","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0515","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: Utility of plasma methoxytyramine","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0520","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2008-1093","article-title":"Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene","volume":"93","author":"Timmers","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0525","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: Recommendations for clinical practice from the First International Symposium, October 2015","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0530","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1373\/clinchem.2012.182246","article-title":"Pheochromocytoma","volume":"59","author":"Eisenhofer","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.hipert.2018.06.003_bib0535","first-page":"19","article-title":"Marcadores biol\u00f3gicos en TNE-GEP: 5HIAA, cromogranina s\u00e9rica, catecolaminas","volume":"39","author":"Belli","year":"2009","journal-title":"Acta Gastroenterol Latinoam."},{"key":"10.1016\/j.hipert.2018.06.003_bib0540","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0032-1309007","article-title":"Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass","volume":"120","author":"Unger","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.hipert.2018.06.003_bib0545","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jc.2007-1354","article-title":"Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma","volume":"93","author":"Algeciras-Schimnich","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0550","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2265.2006.02591.x","article-title":"The role of chromogranin A in the management of patients with phaeochromocytoma","volume":"65","author":"Grossrubatscher","year":"2006","journal-title":"Clin Endocrinol."},{"issue":"Suppl 1","key":"10.1016\/j.hipert.2018.06.003_bib0555","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.33549\/physiolres.931502","article-title":"Chromogranin A: A member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma","volume":"57","author":"B\u00edlek","year":"2008","journal-title":"Physiol Res."},{"key":"10.1016\/j.hipert.2018.06.003_bib0560","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-150-1-200901060-00006","article-title":"Brief communication: Radiographic contrast infusion and catecholamine release in patients with pheochromocytoma","volume":"150","author":"Baid","year":"2009","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.hipert.2018.06.003_bib0565","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00330-008-1073-z","article-title":"Adrenal phaeochromocytoma: Correlation of MRI appearances with histology and function","volume":"18","author":"Jacques","year":"2008","journal-title":"Eur Radiol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0570","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0720-048X(01)00444-2","article-title":"Imaging of adrenal masses","volume":"41","author":"Lockhart","year":"2002","journal-title":"Eur J Radiol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0575","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.suc.2014.03.002","article-title":"Radiographic evaluation of nonfunctioning adrenal neoplasms","volume":"94","author":"Mazzaglia","year":"2014","journal-title":"Surg Clin North Am."},{"key":"10.1016\/j.hipert.2018.06.003_bib0580","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","article-title":"123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation","volume":"69","author":"Bhatia","year":"2008","journal-title":"Clin Endocrinol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)37119-7","article-title":"Extra-adrenal pheochromocytoma","volume":"147","author":"Whalen","year":"1992","journal-title":"J Urol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0590","first-page":"350","article-title":"Images of pheochromocytoma in adrenal glands","volume":"4","author":"McDermott","year":"2015","journal-title":"Gland Surg."},{"key":"10.1016\/j.hipert.2018.06.003_bib0595","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2214\/AJR.07.2107","article-title":"Added value of SPECT\/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma","volume":"190","author":"Rozovsky","year":"2008","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0600","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.semnuclmed.2011.03.003","article-title":"Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer","volume":"41","author":"Ilias","year":"2011","journal-title":"Semin Nucl Med."},{"key":"10.1016\/j.hipert.2018.06.003_bib0605","first-page":"122","article-title":"Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: A systematic review","volume":"57","author":"Rufini","year":"2013","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"10.1016\/j.hipert.2018.06.003_bib0610","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/ERC-15-0175","article-title":"15 years of paraganglioma: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma","volume":"22","author":"Castinetti","year":"2015","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.hipert.2018.06.003_bib0615","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ncpendmet0097","article-title":"The genetic basis of pheochromocytoma: Who to screen and how?","volume":"2","author":"Plouin","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0620","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science."},{"key":"10.1016\/j.hipert.2018.06.003_bib0625","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/joim.12507","article-title":"Precision medicine in pheochromocytoma and paraganglioma: Current and future concepts","volume":"280","author":"Bj\u00f6rklund","year":"2016","journal-title":"J Intern Med."},{"key":"10.1016\/j.hipert.2018.06.003_bib0630","doi-asserted-by":"crossref","DOI":"10.1055\/s-2004-830835","article-title":"Germline mutations in non-syndromic pheochromocytoma","volume":"36","author":"Neumann","year":"2004","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.hipert.2018.06.003_bib0635","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.hipert.2018.06.003_bib0640","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.beem.2010.05.001","article-title":"Genetics of pheochromocytomas and paragangliomas","volume":"24","author":"Opocher","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0645","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cen.12530","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: A systematic review","volume":"82","author":"Brito","year":"2015","journal-title":"Clin Endocrinol."},{"issue":"5\u20136","key":"10.1016\/j.hipert.2018.06.003_bib0650","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12672-015-0231-4","article-title":"Pheochromocytoma: Gasping for air","volume":"6","author":"Jochmanov\u00e1","year":"2015","journal-title":"Horm Cancer."},{"key":"10.1016\/j.hipert.2018.06.003_bib0655","series-title":"GeneReviews.","article-title":"Hereditary paraganglioma-pheochromocytoma syndromes","author":"Kirmani","year":"2008"},{"key":"10.1016\/j.hipert.2018.06.003_bib0660","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.beem.2010.01.002","article-title":"VHL disease","volume":"24","author":"Barontini","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2018.06.003_bib0665","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.hipert.2018.06.003_bib0670","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat Genet."},{"key":"10.1016\/j.hipert.2018.06.003_bib0675","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-319-29998-3_7","article-title":"Diagnosis and management of hereditary phaeochromocytoma and paraganglioma","author":"Lalloo","year":"2016","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.hipert.2018.06.003_bib0680","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.hipert.2018.06.003_bib0685","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","article-title":"DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers","volume":"21","author":"de Cubas","year":"2015","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.hipert.2018.06.003_bib0690","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1677\/ERC-10-0142","article-title":"MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets","volume":"17","author":"Meyer-Rochow","year":"2010","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.hipert.2018.06.003_bib0695","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/ERC-11-0308","article-title":"The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma","volume":"19","author":"Patterson","year":"2012","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.hipert.2018.06.003_bib0700","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4158\/EP161718.RA","article-title":"Precision medicine: An update on genotype\/biochemical phenotype relationships in pheochromocytoma\/paraganglioma patients","volume":"23","author":"Gupta","year":"2017","journal-title":"Endocr Pract."}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183718300898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183718300898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:13Z","timestamp":1784596513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183718300898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1889183718300898"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2018.06.003","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enfoque diagn\u00f3stico de feocromocitomas y paragangliomas","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEH-LELHA. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}